4886 — ASKA Pharmaceutical Holdings Co Balance Sheet

0.000.00%

Last trade - 00:00

Annual balance sheet for ASKA Pharmaceutical Holdings Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Tanshin	Yuho	Yuho	Yuho	Yuho
Standards:	—	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10,514	17,103	17,905	17,238	11,158
Net Total Accounts Receivable
Net Total Receivables	13,153	14,482	15,217	15,579	15,090
Total Inventory
Total Other Current Assets
Total Current Assets	39,932	49,557	53,759	56,143	58,047
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12,675	10,936	10,796	11,263	18,709
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	82,582	83,297	87,138	90,745	100,534
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	16,737	16,011	17,650	23,968	22,879
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	38,072	34,405	32,605	28,815	35,224
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	44,510	48,892	54,533	61,930	65,310
Total Liabilities & Shareholders' Equity	82,582	83,297	87,138	90,745	100,534
Total Common Shares Outstanding